Subjects ” General neurology
HealthDay News – The U.S. Food and Drug Administration issued a new warning for the Johnson & Johnson COVID-19 vaccine stating the shot was linked to Guillain-Barré syndrome.
Officials said there was “a small possible risk” for the side effect and it was not entirely clear that it was caused by the vaccine, the Associated Press reported.
About 100 preliminary reports of Guillain-Barré were discovered after 12.8 million doses of the Johnson & Johnson vaccine were administered, the U.S. Centers for Disease Control and Prevention said in a statement, the Washington Post reported. For the most part, these cases were reported about two weeks after vaccination and occurred mainly in men, many of them ages 50 and older. Most people make a full recovery, but some have permanent nerve damage, according to the CDC.
Continue reading
The available data do not show a pattern suggesting a similar increased risk with the Pfizer and Moderna mRNA vaccines. The Guillain-Barré cases will be discussed at an upcoming meeting of CDC advisors, the agency said, according to The Post.
Associated press article
The Washington Post article
Subjects:
COVID19 COVID19 Vaccine General Infectious Diseases General Neurology Guillain-Barré Syndrome
Would you like to read more?
Please log in or register first to view this content.
Login Register
to open
Next post in General Neurology
Shut down
More Information About FDA Adds Guillain-Barré Warning On J&J COVID-19 Vaccine
Loading… 
More Information About FDA Adds Guillain-Barré Warning On J&J COVID-19 Vaccine
Loading…
More Information About FDA Adds Guillain-Barré Warning On J&J COVID-19 Vaccine
Loading…
More Information About FDA Adds Guillain-Barré Warning On J&J COVID-19 Vaccine
Loading…
Would you like to see more content from Neurology Advisor?
Register now for free to access unlimited clinical news with personalized daily tips for you, Full-length features, case studies, conference coverage, and more.
{{login-button}} {{register-button}}
Would you like to read more?
Please log in or register first to view this content.
Login Register
